Lonafarnib | m-entrepreneurship.com

Product Name :
Lonafarnib

Search keywords :
Lonafarnib

drugId :
null

Target Vo:
Protein farnesyltransferase

Target Vo Short Name :
Ftase

Moa_Name:
Protein farnesyltransferase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Anges Inc

Active Indication_Name:
Progeria

In Active Indication_Name:
Leukemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Smad1 (Ser463/Ser465) Rabbit mAb custom synthesis
BTK (YP5017) Mouse mAb In Vivo
Phospho-IKB alpha (Ser32) Antibody (YA183): Phospho-IKB alpha (Ser32) Antibody (YA183) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha(S32). It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts